Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Duality, Glenmark, Macrogenics, Modular Medical, Novo Nordisk.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anumana, Bausch + Lomb, Becton Dickinson, Cortec, Endospan, Etiometry, GSK, Plus, United, Waters.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artivion, Ascendis, Baylis, Climb Bio, Invera, Neuropacs, Nextcure, Nuvalent, NX Development, Organogenesis, Outlook, Royal Biologics, Savara.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allevion, Regeneron, Stereotaxis.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Abbisko, Eisai, GSK, Merck, SS Innovations.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: A2 Biotherapeutics, Abbisko, Baebies, Bioxcel, Chiesi, Cogent, Orca, Ray, Restore Robotics, Serenity, Vertex.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Ascendis, Elevar, Haemonetics, Medibeacon, Oculis, Polypid, Praxis, Sanofi, Scholar Rock.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Anumana, Biogen, Boston Scientific, Bridgebio, Butterfly, Chiesi, Egetis, Eisai,Elevar, GSK, Merck, Nanoscope, Roche, Savara, SS Innovations, Sobi, Teva, Zymeworks.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Deciphera, Eisai, GC, GSK, Immunitybio, Mars Bioimaging, Nuvation, Ono, OS Therapies, Pharming, Regeneron, Sanofi, Tarsus, Viatris.